Patent Assignment
Reel/Frame 063464/0648
Assignment of Assignor's Interest
Recorded: 2023-04-27
Pages: 3
Assignor
SPARCBIO LLC
Executed: 2022-07-18
Assignee
NUVATION BIO INC.
1500 BROADWAY, STE. 1401, NEW YORK, NEW YORK, 10036
Covered Property
(1)
Anti-Cancer Nuclear Hormone Receptor-Targeting Compounds
Patent:
11,834,458 →
Application:
17/701,425 →
Publication:
US 2022/0340587
PCT:
PCT/US2022/021390 ↗
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 27, 2023
From: KANKANALA, JAYAKANTH; PETTIGREW, JEREMY DAVID; PHAM, SON MINH
To: SPARCBIO LLC
Reel/Frame 063464/0552 →
Assignment of Assignor's Interest
Apr 27, 2023
From: HUNG, DAVID; MILLER, CHRISTOPHER PAUL; DARWISH, IHAB S.
To: NUVATION BIO INC.
Reel/Frame 063464/0884 →
Security Interest
Mar 4, 2025
From: NUVATION BIO INC.
To: SAGARD HOLDINGS MANAGER LP, AS ADMINISTRATIVE AGENT
Reel/Frame 070400/0200 →
Release of Security Interest
Jul 6, 2026
From: SAGARD HOLDINGS MANAGER LP, AS ADMINISTRATIVE AGENT
To: NUVATION BIO INC.
Reel/Frame 075179/0564 →